Abstract:Background: Since chronic apical periodontitis (CAP) appears to be a risk factor for coronary heart disease, the aim of the study was to determine the relationship between the size of CAP lesion and inflammatory markers (hsCRP, IL-6, TNF-α), as well as lipids and lipoproteins (LpPLA2, apoAI, apoB level) in blood serum of patients with CAP. Methods: The patients studied (n = 43) were divided into groups: patients under 50 and over 50 years of age, and a separate subgroup of the oldest age with the largest size of CAP lesions. Apolipoprotein AI (apoAI) above 150 mg/dL and below 150 mg/dL was used as an important criterion for the division of patients into groups. The CAP lesion size was measured using the Kodak digital imaging system software. The control group consisted of clinically healthy volunteers (n = 20) without CAP. Lipids were measured on a Siemens analyzer (Germany), apoAI, apoB, hsCRP levels were determined by immunonephelometric method, using the Health Care Diagnostic Product (Siemens GmbH, Germany), and IL-6, TNF-α and LpPLAG7 assay kits (ELISA, R&D Systems) were used. Results: The findings suggested that in patients with CAP and their age increase, the CAP lesion size, the concentration of inflammatory markers and LpPLA2 mass increased. Correlations between the CAP lesion size and LpPLA2 mass and between the CAP lesion size and TG level in patients with apoAI 150 ≤ mg/dL showed increase TG in atherogenic apoB-containing triglyceride-rich lipoprotein and TC in cholesterol-rich lipoprotein. The patients with a low apoAI and high LpPLA2 level can have a higher risk of odontogenic disease and progression of atherosclerosis and coronary heart disease. Conclusion: We have found a positive correlation between apoAI level and the CAP lesion size and a negative correlation between LpPLA2 level and the CAP lesion size. The results suggest that apoAI and LpPLA2 in HDL particles have antiinflammatory action and together can limit the CAP lesion size in patient with a higher apoAI level. The literature data on the distribution of lipoprotein particles in subjects are still insufficient, so this problem requires further studies.

Lipoprotein-associated Phospholipase A2 and Serum Lipid Levels in Subjects with Chronic Periodontitis and Hyperlipidaemia

Association Of Periodontal Parameters With Metabolic Level And Systemic Inflammatory Markers In Patients With Type 2 Diabetes

Hyperglucose Contributes to Periodontitis: Involvement of the NLRP3 Pathway by Engaging the Innate Immunity of Oral Gingival Epithelium.

The Association between Periodontal Status, Serum Lipid Levels, Lipoprotein Associated Phosholipase A2 (Lp-PLA2) in Chronic Periodontitis Subjects and Healthy Controls

Periodontal therapy improved lipoprotein-associated phospholipase A2 and lipid levels in serum of chronic periodontitis subjects with hyperlipidemia

Association Between Plasma Lysophosphatidic Acid and Coronary Stenosis with Coronary Heart Disease

Blood Lipids and Glucose Levels in Patients with Periodontitis

Plasma lipid and blood glucose levels in patients with destructive periodontal disease

Lipids and lipoproteins and inflammatory markers in patients with chronic apical periodontitis

Association between periodontitis and hyperlipidaemia: A systematic review and meta‐analysis

Effect of periodontal inflammation on serum CRP levels in patients with coronary heart disease

The association between high-density lipoproteins and periodontitis

Periodontal Parameters and Platelet-Activating Factor Levels in Serum and Gingival Crevicular Fluid in a Chinese Population.

Platelet-activating Factor Levels of Serum and Gingival Crevicular Fluid in Nonsmoking Patients with Periodontitis And/or Coronary Heart Disease

[Effect of Periodontal Initial Therapy on the Serum Level of Lipid in the Patients with Both Periodontitis and Hyperlipidemia].

Change of Oxidized Low Density Lipoproteins and Fibrinogen in the Patients of Coronary Heart Disease with Chronic Periodontitis

Inflammatory Cytokine Levels in Patients with Periodontitis And/Or Coronary Heart Disease

The effect of periodontal inflammatory on the level of hs-CRP in diabetes patients with periodontitis of Guangzhou area

Effect of Non-surgical Periodontal Therapy on Serum Levels of TNF-α , IL-6 and C-reactive Protein in Periodontitis Subjects with Stable Coronary Heart Disease

Elevation of C-reactive protein and interleukin-6 in plasma of patients with aggressive periodontitis

Glucose and Lipid Metabolism Indexes and Blood Inflammatory Biomarkers of Patients with Severe Periodontitis: A Cross-Sectional Study.